Pharmaceutical Blog Chatter Continues About Dr. Steven Nissen’s Avandia Revelations, Most Bloggers Refute
NEWTOWN, PA, June 1, 2007 – This week, pharmaceutical bloggers spent much of their time refuting Dr. Steven Nissen’s Avandia study results. Also in the blogs is discussion of AstraZeneca squashing its pink cupcake plans. Christiane Truelove, editor of Med Ad News and R&D Directions, summarizes bloggers’ thoughts in this week’s edition of the PharmaBlogs: Week in Review e-newsletter.
David Phillips at the 10Q Detective blog criticizes the media for running Dr. Nissen’s Avandia study results without regard for statistical flaws and biases. The blog also worries that type 2 diabetes patients may stop taking Avandia without telling their doctors after reading these news stories. Furthermore, 10Q Detective questions Dr. Nissen’s relationship with Eli Lilly and Co., the marketers of Avandia competitor, Actos.
AstraZeneca released a memo to sales reps forbidding them from giving any flowers, food, or beverages as had been previously planned for the company’s Mothers United for Mammograms (MuMs) program. Bloggers speculate that the distribution of items to patients may have caused legal issues for AstraZeneca.
Pharma professionals who wish to subscribe to PharmaBlogs: Week in Review may visit www.pharmalive.com/enewsletters.
About PharmaBlogs: Week in Review
Designed as a time-effective approach to keeping current on the
industry’s blog discussions, PharmaBlogs: Week in Review is
the first online newsletter focused on recapping pharmaceutical
blogs. The e-newsletter is published by industry information
provider Engel Publishing Partners and sent to your e-mail inbox
each Friday.
About Engel Publishing Partners
For 25 years, Engel Publishing Partners has been the source that
pharmaceutical executives turn to for the information they need to
create competitive business strategies. Engel Publishing Partners
carries a full product line, offering industry-leading publications
Med Ad News and R&D Directions, informative newsletters, and
data-rich interactive products. Through these channels, Engel
Publishing Partners disseminates original and un-biased content
that provides insight into industry trends and events, as well as
extensive analysis of companies, products, and pipelines.
Pharma Industry News Archive
2007: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2006: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2005: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2004: Jan | Feb | Mar | Apr | May | Jul | Aug | Sep | Oct | Nov | Dec
2003: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2002: Jan | Apr | May | Jun | Aug | Sep | Oct | Nov | Dec
